Chapter 27. Respiratory Medicine

  1. David Machin2,3,4,
  2. Simon Day5 and
  3. Sylvan Green6
  1. Anders Källén

Published Online: 17 MAY 2007

DOI: 10.1002/9780470010167.ch27

Textbook of Clinical Trials, Second Edition

Textbook of Clinical Trials, Second Edition

How to Cite

Källén, A. (2006) Respiratory Medicine, in Textbook of Clinical Trials, Second Edition (eds D. Machin, S. Day and S. Green), John Wiley & Sons, Ltd, Chichester, UK. doi: 10.1002/9780470010167.ch27

Editor Information

  1. 2

    Division of Clinical Trials and Epidemiological Sciences, National Cancer Centre Singapore, 11 Hospital Drive, Singapore 16910, Singapore

  2. 3

    UK Children's Cancer Study Group, University of Leicester, UK

  3. 4

    Medical Statistics Group, School of Health and Related Sciences, University of Sheffield, UK

  4. 5

    Licensing Division, Medicines and Healthcare products Regulatory Agency, Room 13–205 Market Towers, 1 Nine Elms Lane, London SW8 5NQ, UK

  5. 6

    Arizona Cancer Centre, Tucson, Arizona, USA

Author Information

  1. Jullovsvagen 13, S-224 67 Lund, Sweden

Publication History

  1. Published Online: 17 MAY 2007
  2. Published Print: 24 NOV 2006

ISBN Information

Print ISBN: 9780470010143

Online ISBN: 9780470010167

SEARCH

Keywords:

  • airway obstruction and respiratory medicine;
  • non-specific bronchial hyperresponsiveness;
  • glucocorticosteroids (GCSs) on asthma, rhinitis;
  • marketing therapeutic equivalence;
  • placebo-controlled dose–response study and minimal effective dose (MED)

Summary

This chapter contains sections titled:

  • Airways Diseases

  • Clinical Trial Methods

  • Phase I/II Studies

  • Phase III Studies

  • Other Issues

  • References